[go: up one dir, main page]

EA200900646A1 - Способ получения твердой фармацевтической композиции, содержащей валсартан - Google Patents

Способ получения твердой фармацевтической композиции, содержащей валсартан

Info

Publication number
EA200900646A1
EA200900646A1 EA200900646A EA200900646A EA200900646A1 EA 200900646 A1 EA200900646 A1 EA 200900646A1 EA 200900646 A EA200900646 A EA 200900646A EA 200900646 A EA200900646 A EA 200900646A EA 200900646 A1 EA200900646 A1 EA 200900646A1
Authority
EA
Eurasian Patent Office
Prior art keywords
valsartan
particles
pharmaceutical composition
composition containing
obtaining
Prior art date
Application number
EA200900646A
Other languages
English (en)
Other versions
EA015108B1 (ru
Inventor
Мига Врбинц
Яника Сланц Вовк
Мария Рангус
Силво Зупанчич
Франци Бевец
Лидия Черноша
Original Assignee
Крка, Д.Д. Ново Место
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35966966&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200900646(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP04030782A external-priority patent/EP1674080A1/en
Application filed by Крка, Д.Д. Ново Место filed Critical Крка, Д.Д. Ново Место
Publication of EA200900646A1 publication Critical patent/EA200900646A1/ru
Publication of EA015108B1 publication Critical patent/EA015108B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Данное изобретение относится к способу получения твердой фармацевтической композиции, содержащей частицы валсартана, где Dуказанных частиц валсартана составляет 150 мкм или менее, и где частицы валсартана имеют максимальный диаметр не более 1100 мкм, как определено с помощью электронной микроскопии, который включает следующие стадии: получение частиц валсартана, имеющих максимальный диаметр 1100 мкм, - грануляцию смеси эксципиентов с использованием воды или водной дисперсии в качестве грануляционной жидкости с получением гранулята, добавление частиц валсартана и дополнительных эксципиентов к указанному грануляту с получением смеси для прессования, прессование этой смеси для прессования в желаемую форму, возможно, нанесение покрытия.
EA200900646A 2004-12-24 2005-12-23 Способ получения твердой фармацевтической композиции, содержащей валсартан EA015108B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04030782A EP1674080A1 (en) 2004-12-24 2004-12-24 Solid pharmaceutical composition comprising valsartan
EP05004433 2005-03-01

Publications (2)

Publication Number Publication Date
EA200900646A1 true EA200900646A1 (ru) 2009-10-30
EA015108B1 EA015108B1 (ru) 2011-06-30

Family

ID=35966966

Family Applications (2)

Application Number Title Priority Date Filing Date
EA200900646A EA015108B1 (ru) 2004-12-24 2005-12-23 Способ получения твердой фармацевтической композиции, содержащей валсартан
EA200701107A EA012392B1 (ru) 2004-12-24 2005-12-23 Твердая фармацевтическая композиция, содержащая валсартан

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA200701107A EA012392B1 (ru) 2004-12-24 2005-12-23 Твердая фармацевтическая композиция, содержащая валсартан

Country Status (16)

Country Link
US (1) US20080102120A1 (ru)
EP (2) EP1833464A1 (ru)
CN (1) CN101087589B (ru)
AU (1) AU2005318365B2 (ru)
CA (1) CA2592091A1 (ru)
DK (1) DK2033629T3 (ru)
EA (2) EA015108B1 (ru)
ES (1) ES2397552T3 (ru)
HR (1) HRP20130033T1 (ru)
ME (1) ME01453B (ru)
NO (1) NO20073889L (ru)
PL (1) PL2033629T3 (ru)
PT (1) PT2033629E (ru)
RS (1) RS52607B (ru)
SI (1) SI2033629T1 (ru)
WO (1) WO2006066961A1 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2697660C2 (ru) * 2015-02-05 2019-08-16 Борюн Фармасьютикал Ко., Лтд. Таблетка и способ ее получения

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1897537A1 (en) * 2006-09-04 2008-03-12 Novartis AG Composition comprising an angiotensin II receptor antagonist
PE20081364A1 (es) * 2006-09-04 2008-12-04 Novartis Ag Composicion farmaceutica que comprende valsartan
WO2008076780A2 (en) * 2006-12-14 2008-06-26 Isp Investments Inc. Amorphous valsartan and the production thereof
TR200703568A1 (tr) * 2007-05-24 2008-07-21 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Valsartan formülasyonları
GB0715628D0 (en) * 2007-08-10 2007-09-19 Generics Uk Ltd Solid valsartan composition
WO2009113091A2 (en) * 2008-01-24 2009-09-17 Usv Limited Pharmaceutical compositions comprising valsartan
EP2405899A2 (en) * 2009-03-11 2012-01-18 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Valsartan formulations
SI2536396T1 (sl) 2010-02-16 2017-01-31 KRKA, tovarna zdravil, d.d.,Novo mesto Postopek za pripravo oralnih trdnih odmernih oblik, ki obsegajo valsartan
CN102119912A (zh) * 2011-01-25 2011-07-13 南京白敬宇制药有限责任公司 一种非水溶性药物缓释制剂的制备方法
CN102204907A (zh) * 2011-03-31 2011-10-05 北京赛科药业有限责任公司 一种含缬沙坦的药物组合物及其制备方法
WO2013098578A1 (en) 2011-12-31 2013-07-04 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Immediate release pharmaceutical composition of valsartan hydrochlorothiazide
WO2013098576A1 (en) 2011-12-31 2013-07-04 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Immediate release pharmaceutical composition of valsartan
CN103599084B (zh) * 2013-11-22 2018-10-30 威海迪素制药有限公司 一种降压组合物
CN104887640B (zh) * 2015-06-30 2017-12-19 昆明医科大学 一种含有缬沙坦的固体药物组合物
US20210267908A1 (en) * 2020-03-02 2021-09-02 Mankind Pharma Ltd. Pharmaceutical compositions of rivaroxaban
CN112098408B (zh) * 2020-09-14 2022-12-09 湖北亿纬动力有限公司 一种羧甲基纤维素钠溶解效果的检测方法及应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122010000024I1 (de) * 1990-02-19 2010-07-08 Novartis Ag Acylverbindungen
GB9613470D0 (en) * 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
ATE354364T1 (de) 1998-12-23 2007-03-15 Novartis Pharma Gmbh Verwendung von at-1 rezeptorantagonisten oder at- 2 rezeptormodulatoren zur behandlung von erkrankungen, die mit einer erhöhung an at-1 oder at-2 rezeptoren verbunden sind
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6211217B1 (en) * 1999-03-16 2001-04-03 Novartis Ag Method for reducing pericardial fibrosis and adhesion formation
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
WO2001076574A2 (en) * 2000-04-12 2001-10-18 Novartis Ag Novel medical use of aldosterone synthase inhibitors alone or in combination with at1-receptor antagonists
US6499984B1 (en) * 2000-05-22 2002-12-31 Warner-Lambert Company Continuous production of pharmaceutical granulation
AU8576801A (en) 2000-06-22 2002-01-02 Novartis Ag Pharmaceutical compositions
PE20020613A1 (es) * 2000-07-19 2002-08-07 Novartis Ag Sales de (s)-n-(1-carboxi-2-metil-prop-1-il)-n-pentanoil-n-[2'-(1h-tetrazol-5-il)-bifenil-4-ilmetil]-amina como antagonista del receptor at1
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
PL212318B1 (pl) 2002-01-17 2012-09-28 Novartis Ag Kompozycja farmaceutyczna zawierajaca walsartan oraz inhibitor obojetnej endopeptydazy (NEP) oraz zestaw zawierajacy te kompozycje
CN1726030A (zh) * 2002-12-18 2006-01-25 诺瓦提斯公司 缬沙坦与cox－2抑制剂的组合
ES2238022T3 (es) * 2003-03-17 2008-11-01 Teva Pharmaceutical Industries Ltd. Poliformos de valsartan.
EP1556363A2 (en) * 2003-04-21 2005-07-27 Teva Pharmaceutical Industries Limited Process for the preparation of valsartan and intermediates thereof
WO2004094392A1 (en) * 2003-04-21 2004-11-04 Teva Pharmaceutical Industries Ltd. Process for the preparation of valsartan
US7569612B1 (en) * 2006-08-21 2009-08-04 Mutual Pharmaceutical Company, Inc. Methods of use of fenofibric acid

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2697660C2 (ru) * 2015-02-05 2019-08-16 Борюн Фармасьютикал Ко., Лтд. Таблетка и способ ее получения
US10420728B2 (en) 2015-02-05 2019-09-24 Boryung Pharmaceutical Co., Ltd. Tablet and method of preparing the same

Also Published As

Publication number Publication date
CN101087589B (zh) 2013-01-30
EA012392B1 (ru) 2009-10-30
CA2592091A1 (en) 2006-06-29
DK2033629T3 (da) 2013-02-04
RS52607B (sr) 2013-04-30
HRP20130033T1 (hr) 2013-02-28
WO2006066961A1 (en) 2006-06-29
ES2397552T3 (es) 2013-03-07
PL2033629T3 (pl) 2013-04-30
ME01453B (me) 2014-04-20
EP1833464A1 (en) 2007-09-19
NO20073889L (no) 2007-09-24
SI2033629T1 (sl) 2013-01-31
CN101087589A (zh) 2007-12-12
EP2033629A1 (en) 2009-03-11
US20080102120A1 (en) 2008-05-01
EP2033629B1 (en) 2012-11-14
AU2005318365B2 (en) 2011-02-03
PT2033629E (pt) 2013-01-24
EA015108B1 (ru) 2011-06-30
AU2005318365A1 (en) 2006-06-29
EA200701107A1 (ru) 2008-04-28

Similar Documents

Publication Publication Date Title
EA200900646A1 (ru) Способ получения твердой фармацевтической композиции, содержащей валсартан
MX2009004760A (es) Granulos, tabletas y granulacion.
EP1677159A3 (en) Toner, method for its production and image forming method
EA200702554A1 (ru) Способ получения эпоксида из полигидроксилированного алифатического углеводорода и агента хлорирования
ES2194579B1 (es) Metodo de produccion de fibra que tiene polvo mineral funcional y fibra producida a partir del mismo.
ATE535152T1 (de) Verfahren zur herstellung einer streichbaren dispersion
RU2006116570A (ru) Ускоритель схватывания цемента
EA200970942A1 (ru) Экстракт пажитника сенного (trigonella foenum-graecum)
EA201001852A1 (ru) Твердые фармацевтические составы, содержащие bibw 2992
EA200801468A1 (ru) Препараты ганаксолона и способы их получения и применения
DK1257604T3 (da) Bariumsulfat, fremgangsmåde til fremstilling deraf og dets anvendelse
EP1769867A4 (en) METHOD FOR PRODUCING METAL PARTICLES, METAL PARTICLES PRODUCED THEREwith, SELF-CONTAINING COMPOSITION, LIGHT ABSORBING MATERIAL AND APPLICATION THEREOF
UA96448C2 (ru) Смесь для получения бетона (варианты), премикс вяжущего для получения бетона, композиция подвижной бетонной смеси (варианты), объект из отвердевшего бетона (варианты), способ получения композиции подвижной бетонной смеси (варианты), способ получения литой подвижной бетонной смеси и способ получения объекта из бетона
BRPI0507139A (pt) agregado de celulose porosa, processo para produzir o mesmo, e composição de produto moldado
WO2005072702A3 (en) Method for milling frozen microparticles
MX2009005581A (es) Particulas estables de lactido.
EA200400487A1 (ru) Фармацевтическая композиция длительного высвобождения, содержащая метформин
UA88308C2 (ru) Агент образования олеогеля, который содержит тритерпен, олеогель и способ его получения
ES2422433T3 (es) Procedimiento para la preparación de partículas esféricas a partir de una sustancia farmacéutica
WO2006082501A3 (en) Fast wet-massing method for the preparation of calcium-containing compositions
CA2557107A1 (en) Process for production of ionically crosslinked polysaccharide microspheres
GB2450040A (en) Novel crystallization methods and novel crystalline and amorphous forms of halo-genated sugars
EP1571181A3 (en) Inorganic fine particle dispersion and manufacturing method thereof as well as image-recording material
WO2008058996A3 (de) Verfahren zur herstellung von magnetischen kieselsäurepartikeln
WO2006006155A3 (en) Novel solid compositions for disinfecting water

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU